Literature DB >> 9060080

Evaluation of possible tissue damage in patients undergoing extracorporeal shock wave lithotripsy employing C-reactive protein.

J M Wolff1, P Mattelaer, W Boeckmann, U Kraemer, G Jakse.   

Abstract

Extracorporeal shock wave lithotripsy (ESWL) has become the most common treatment for stones in the upper urinary tract. Tissue injury related to ESWL has been documented. C-reactive protein (CRP) is the classical acute-phase protein most recognized as an early marker in diseases characterized by inflammation and tissue injury. Possible tissue trauma by ESWL was evaluated by serial CRP determinations in 150 patients with kidney stones, whose follow-up was uneventful. The mean CRP-concentration prior to ESWL was 6.34 mg/l. The majority of patients did not show any further elevation of CRP-levels. Mean CRP-levels were 7.62 mg/l on the first, 6.12 mg/l on the third and 5.09 mg/l on the fifth day after ESWL. No correlation was observed between the number of shock waves and CRP levels. Judged by CRP-determinations tissue damage induced by ESWL can be considered to be minimal as no marked CRP-elevations could be observed in patients with an uneventful follow-up after ESWL.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9060080     DOI: 10.3109/00365599709070298

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  2 in total

1.  Neutrophil gelatinase-associated lipocalin (NGAL) value changes before and after shock wave lithotripsy.

Authors:  Matteo Vittori; Silvia Baroni; Pietro Manuel Ferraro; Giovanni Gambaro; Renato Morelli; PierFrancesco Bassi; Alessandro D'Addessi
Journal:  Urolithiasis       Date:  2016-10-27       Impact factor: 3.436

2.  Anaesthesia and the acute phase protein response in children undergoing circumcision.

Authors:  Unase Buyukkocak; Fatma Caglayan; Osman Caglayan; Murat Basar; Murat Cakmak; Ertan Batislam; Sevgi Ulusoy
Journal:  Mediators Inflamm       Date:  2005-10-24       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.